Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Rhabdoid Tumor × Carboplatin × Clear all

Phase

Status

Completed 5 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 72 Breast Neoplasms 34 Triple Negative Breast Neoplasms 24 Ovarian Neoplasms 20 Lung Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 17 Fallopian Tube Neoplasms 17 Small Cell Lung Carcinoma 15 Neoplasm Metastasis 11 Prostatic Neoplasms 10 Esophageal Neoplasms 10 Endometrial Neoplasms 9 Colorectal Neoplasms 9 Neoplasms 8 Uterine Cervical Neoplasms 7 Carcinoma 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Pancreatic Neoplasms 6 Oropharyngeal Neoplasms 6 Urinary Bladder Neoplasms 5 Laryngeal Neoplasms 5 Head and Neck Neoplasms 5 Stomach Neoplasms 4 Mouth Neoplasms 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Carcinoma, Ovarian Epithelial 4 Urothelial Cancer 3 Seminoma 3 Salivary Gland Neoplasms 3

Interventions

X-Rays 6 Phantoms, Imaging 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Biopsy 4 Cyclophosphamide 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 etoposide phosphate 2 erdafitinib 2 ensartinib 2 Topotecan 2 Etoposide 2 tazemetostat 1 pembrolizumab 1 olaparib 1 atezolizumab 1 Vincristine 1 Vemurafenib 1 Tiragolumab 1 Temozolomide 1 Sirolimus 1 Radiotherapy 1 Pharmacogenomic Variants 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡